| Literature DB >> 34368685 |
Dewi Santosaningsih1,2, Dewi Erikawati1, Iffa A Hakim1, Sanarto Santoso1, M Hidayat3, Ayu H Suwenda3, Vicky Puspitasari4, Irhamni Irhamni4, Kuntaman Kuntaman5, Andreas L E van Arkel2, Luke G Terlouw2, Neline Oudenes2, Diana Willemse-Erix2,6, Susan V Snijders2, Nicole S Erler7, Henri A Verbrugh2, Juliëtte A Severin2.
Abstract
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is endemic in healthcare settings in Indonesia. AIM: To evaluate the effect of a bundle of preventive measures on the transmission and acquisition of MRSA in a surgical ward of a resource-limited hospital in Indonesia.Entities:
Keywords: Asia; Indonesia; Infection control; Panton-Valentine leukocidin; Patient isolation; Staphylococcus aureus
Year: 2019 PMID: 34368685 PMCID: PMC8335904 DOI: 10.1016/j.infpip.2019.100028
Source DB: PubMed Journal: Infect Prev Pract ISSN: 2590-0889
Description of the bundle of intervention measures
| Preventive measures against MRSA transmission | Period | ||
|---|---|---|---|
| Pre-intervention phase | Intervention phase | Post-intervention phase | |
| (July 2012–January 2013) | (February 2013–March 2013) | (April 2013–August 2013) | |
| Hand hygiene promotion | Posters of hand hygiene procedure according to the WHO guideline created by infection control team were placed on the wall near the sinks. No systematic and sustainable educational program. | The existing posters were maintained. In addition, we placed 2 bigger posters on the wall of each study ward. Reminders of “five hand hygiene opportunities” were placed on the cover of each medical record. Each healthcare worker working in the study ward was obliged to read the information sheet regarding hand hygiene procedure. Weekly presentation was delivered in the study ward attended by nurses, nurse assistants, pharmacists, and dieticians. | |
| Handrub solution access | Two bottles of 500 mL alcohol-based liquid were placed through wall-fixed dispensers and located in the middle of the study ward. | A bottle of 500 mL chlorhexidine-containing hand glycerin alcohol 0.5% was placed at each bedside. | |
| Hand hygiene compliance observation | The compliance was observed and measured on seven different days. | The compliance was observed and measured 7 times. | The compliance was observed and measured 15 times. |
| Screening of MRSA | Screening of patients1, HCWs2, and hospital environment2 | Screening of patients1, HCWs3, and hospital environment3 | Screening of patients1, HCWs2, and hospital environment2 |
| Cohorting | Not yet implemented. | Patients with MRSA detected at admission were grouped separately from MRSA-negative patients behind a screen in a designated area ( | |
| Decolonization/load reduction therapy | None. | Patients with MRSA detected at admission and MRSA-positive HCWs received decolonization therapy consisting of mupirocin dermatological cream 2% (Bactoderm cream, PT. Ikapharmindo Putramas, Indonesia) to both nares twice daily for five days plus body wash with chlorhexidine-medicated soap 4% (Hibiscrub, Astra Zeneca) for seven days. Patients and HCWs who carried MRSA in their throat were additionally offered trimethoprim/sulfamethoxazole oral therapy 960 mg twice daily for seven days. | |
| Cleaning and disinfection of hospital environment | Not performed. | Cleaning and disinfection of surfaces was conducted once a week using sodium hypochlorite 0.05%. | |
| Disinfection of instruments | Not regularly. | Disinfection of instruments was conducted using alcohol 70% regularly once a week and after use by MRSA-positive patients before being used by MRSA-negative patients. | |
WHO, World Health Organization; MRSA, methicillin-resistant Staphylococcus aureus; HCWs, healthcare workers.
1At admission and either at day-5 or at discharge; 2In the first week and at the end of the phase; 3In the middle of the phase.
Figure 1Flow chart of patients included in the analysis.
The prevalence of MRSA carriage among patients, healthcare workers, and the hospital environment
| Group | Phase | No. of subjects screened | No. of patients without complete screening | No. of patients analysed | No. of cultures (ENV) | Prevalence of MRSA carriage at admission (%; CI95) | MRSA acquisition event | Median of MRSA acquisition rate1 (range) | Prevalence of MRSA carriage (%; CI95) |
|---|---|---|---|---|---|---|---|---|---|
| HCWs3 | PI | 68 | 1/68 (1.5; 0.1–7.9)2 | ||||||
| I | 60 | 3/60 (5.0; 1.7–13.7) | |||||||
| PoI | 94 | 0/942 | |||||||
| Patients | PI | 998 | 426 | 572 | 18/572 (3.1; 2.0–4.9)4 | 30 | 5.3 (0.0–41.0) | ||
| I | 174 | 86 | 88 | 1/88 (1.1; 0.1–6.2) | 2 | 2.8 (0.0–5.6) | |||
| PoI | 765 | 305 | 460 | 11/460 (2.4; 1.3–4.2)4 | 8 | 1.7 (0.0–6.7) | |||
| ENV | 201 | 2/201 (1.0; 0.3–3.6)5 | |||||||
| 100 | 0/100 | ||||||||
| 200 | 1/200 (0.5; 0.0–2.8)5 |
MRSA, methicillin-resistant Staphylococcus aureus; HCWs, healthcare workers; ENV, environment; PI, pre-intervention; I, intervention; PoI, post-intervention.
1Number of acquisition events divided by number of patient-days at risk (per 1000 patient-days); 2P=0.420; 3HCWs who carried MRSA and received decolonization therapy were screened before and after decolonization therapy. 4P=0.589; 5Contamination rate on hospital environment, P=1.000.
Figure 3Methicillin-resistant Staphylococcus aureus acquisitions among patients versus hand hygiene compliance rate among healthcare workers. The solid horizontal line represents the average of acquisition rate, the grey area represents the 95% confidence interval around that mean. The dashed horizontal line represents the average of hand hygiene compliance. PI=pre-intervention phase; I= intervention phase; PoI=post-intervention phase.
Figure 4Trend of hand hygiene compliance during the study period. PI, pre-intervention phase; I, intervention phase; PoI, post-intervention phase.
The compliance to the five moments of hand hygiene before/during the intervention and in the post-intervention phase
| Hand hygiene moment | Total | ||
|---|---|---|---|
| Compliance (%) | OR (95% CI) | ||
| PI and I | PoI | ||
| 1 | 9.5 | 84.7 | 52.8 (31.2–89.2) |
| 2 | 3.6 | 39.8 | 17.8 (8.6–36.7) |
| 3 | 36.7 | 70.3 | 4.1 (2.1–8.0) |
| 4 | 39.7 | 64.8 | 2.8 (2.1–3.8) |
| 5 | 34.9 | 61.8 | 3.0 (2.4–3.7) |
OR, odds ratio; PI, pre-intervention phase; I, intervention phase, PoI, post-intervention phase.
Moment 1, before touching a patient; moment 2, before clean/aseptic procedure; moment 3, after body fluid exposure risk; moment 4, after touching a patient; moment 5, after touching patient surroundings.
p<0.001 (Fisher's exact test).
p<0.001 (χ2).
Figure 5Raman spectra of methicillin-resistant Staphylococcus aureus isolates.The correlation matrix displayed is used to analyse the relatedness between isolates. Red clusters show isolates that are indistinguishable based on the cut-off value. The grey areas indicate isolates that are not related based on the similarity threshold. Yellow areas to orange areas gradually show the potentially related isolates. RT9 includes 39 MRSA isolates from patients (pre-intervention: 15 isolates and post-intervention: 24 isolates) and one MRSA isolate from the environment in the post-intervention phase. RT11 contains 15 MRSA isolates from patients (pre-intervention: 2 isolates, intervention: 3 isolates, post-intervention: 10 isolates). RT8 consists of 10 PVL-positive MRSA isolates from patients in the postimplementation phase.
Figure 6Endemicity profile of large clusters of MRSA assigned to RT9, RT11, and RT8. Month 1–7=pre-intervention phase; month 8–9=implementation of intervention phase; month 10–14=post-intervention phase. MRSA, methicillin-resistant Staphylococcus aureus; RT, Raman type.
Results of Raman spectroscopy analysis and MLST of 10 selected methicillin-resistant Staphylococcus aureus isolates
| Isolate number | Raman type | Sequence type |
|---|---|---|
| PPoM 10458a | 8 | 772 |
| PPiM 10293b | 9 | 239 |
| PPiM 10756b | 9 | 239 |
| PPoM 20544a | 9 | 239 |
| PPoM 20673a | 9 | 239 |
| HI 1097c | 10 | 8 |
| PPoH 10221d | 11 | 239 |
| PPoM 10212a | 11 | 239 |
| PIK 10127e | 11 | 239 |
| PPiM 10495b | 15 | 789 |
aisolated from patients at admission in the post-intervention phase; bisolated from patients at admission in the pre-intervention phase; cisolated from healthcare worker in the intervention phase; disolated from patients at day-5 admission in the post-intervention phase; eisolated from patients at discharge in the intervention phase.